Equity Structure. Sponsor shall have invested a minimum of $50,000,000 ($45,000,000 of such $50,000,000 will be used by the Borrower on the Restatement Effective Date to finance the Restatement Effective Date Merger and $5,000,000 of such $50,000,000 will be used by the Borrower on or after the Restatement Effective Date to finance Capital Expenditures) into the Borrower, directly or indirectly, in the form of cash equity into the capital stock or other equity securities of Borrower.
Equity Structure. The Sponsor and/or its Controlled Investment Affiliates and other co-investors reasonably acceptable to the Purchasers shall have invested a minimum of 30.0% of the total pro forma capitalization of the Issuer and its Subsidiaries on the Original Closing Date, directly or indirectly, in the form of cash equity into the capital stock or other equity securities of the Issuer, it being understood that investments in preferred equity securities must be on terms and conditions reasonably satisfactory to the Purchasers.
Equity Structure. Schedule 2.22(b) of the Seller Disclosure Letter sets forth, as of the Agreement Date, the issued Equity Interests of the China JV and their holders of record. The Company owns the Equity Interests of the China JV as set out against the Company’s name in such Schedule, free and clear of all Encumbrances. There are no issued, reserved for issuance, promised and ungranted or outstanding options, warrants, stock appreciation rights, restricted share units, phantom stock, calls, subscriptions or other rights to acquire from the China JV or other obligations of the China JV to issue or allot, any Equity Interests, other than under the China JV 2019 Equity Incentive Plan approved and adopted by the board of directors of the China JV on November 13, 2019, pursuant to which options exercisable for up to 13.3285% of the registered capital of the China JV were reserved.
Equity Structure. The equity structure of the Borrower and each of its subsidiaries, including each class of its capital stock and other securities, is set forth on Schedule 5(p). Each of the Borrower's subsidiaries is wholly-owned, directly or indirectly through one or more subsidiaries, by the Borrower.
Equity Structure. (a) The authorized capital stock of the Seller consists solely of (i) 100,000,000 shares of Common Stock of which, as of the date of the Agreement, 16,871,557 shares were issued and outstanding and (ii) 25,000,000 shares of Series A Voting Cumulative Preferred Stock, none of which is issued or outstanding. All of the outstanding shares of Common Stock have been validly issued and are fully paid, nonassessable and free of preemptive rights. As of the date of this Agreement, 10,189,523 shares of Common Stock were reserved for issuance and issuable upon or otherwise deliverable in connection with the exercise of outstanding options, warrants or other rights or securities convertible into shares of Common Stock ("Company Options"), which Company Options are listed (including type and amount of Company Option, option holder's name and option price) in Exhibit 3.16(a). Except as set forth above, there are outstanding: (i) no shares of capital stock or other voting securities of the Company, (ii) no securities of the Company or its subsidiaries convertible into or exchangeable for shares of capital stock or voting securities of the Company, (iii) no options, warrants, subscriptions, calls, rights or other agreements to acquire from the Company or its subsidiaries, and no obligations of the Company or its subsidiaries to issue, any capital stock, voting securities or securities of the Company and (iv) no equity equivalent interests or rights to acquire equity equivalent interests in the ownership or earnings of the Company or its subsidiaries other similar rights (collectively "Company Securities"). As of the date hereof, there are no outstanding obligations of the Company or its subsidiaries to repurchase, redeem or otherwise acquire any Company Securities. There are no stockholder agreements, voting trusts or other agreements or understandings to which the Company is a party or by which it is bound relating to the voting or registration of any shares of capital stock of the Company or other Company Securities, and to the knowledge of the Company, no such agreements have been entered into by shareholders of the Company.
Equity Structure. FINOVA shall have reviewed and approved Borrower's organizational documents and the ownership structure of Borrower.
Equity Structure. The Company has the following capital structure:
Equity Structure. It is the intention of the Shareholders that the shareholdings in the UFSB shall be held in the respective proportions as set out below: Shareholders Percentage SASB 50% DASB 50% Total 100%
Equity Structure. The equity structure of Dentex and its subsidiaries, including each class of their capital stock and other securities, is set forth on Schedule 5(p). Each of Dentex's subsidiaries is wholly owned, directly or indirectly through one or more subsidiaries, by Dentex.
Equity Structure. Other than the issue of Shares in accordance with this Agreement or any management incentive program approved by Valspar and Champion Regal, any corporate action which alters the equity structure of the Company such as the issuing of new shares, the granting of an option to subscribe for shares, the redemption of shares, the buy back of shares, the reduction or conversion of capital or variation of the authorised share capital of the Company.
